汇宇制药(688553)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688553 汇宇制药

已收盘 05-15 15:00:00

{"stockData":{"symbol":"688553","market":"SH","secType":"STK","nameCN":"汇宇制药","latestPrice":13.59,"timestamp":1747292400000,"preClose":13.71,"halted":0,"volume":1750111,"delay":0,"changeRate":-0.0088,"floatShares":344000000,"shares":424000000,"eps":0.5981,"marketStatus":"已收盘","change":-0.12,"latestTime":"05-15 15:00:00","open":13.77,"high":13.77,"low":13.57,"amount":23887300,"amplitude":0.0146,"askPrice":13.59,"askSize":251,"bidPrice":13.58,"bidSize":105,"shortable":0,"etf":0,"ttmEps":0.5981,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747359000000},"marketStatusCode":5,"adr":0,"adjPreClose":13.71,"symbolType":"stock_kcb","openAndCloseTimeList":[[1747272600000,1747279800000],[1747285200000,1747292400000]],"highLimit":15.08,"lowLimit":12.34,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":423600000,"isCdr":false,"pbRate":1.46,"roa":"--","peRate":22.721953,"roe":"--","epsLYR":0.77,"committee":0.361345,"marketValue":5757000000,"turnoverRate":0.0051,"status":1,"afterMarket":{"amount":0,"volume":0,"close":13.59,"buyVolume":0,"sellVolume":0,"time":1747294438029,"indexStatus":"已收盘 05-15 15:30:00","preClose":13.71},"floatMarketCap":4669000000},"requestUrl":"/m/hq/s/688553","defaultTab":"news","newsList":[{"id":"2535689935","title":"汇宇制药：张春平正式履职董事会秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2535689935","media":"公司公告","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535689935?lang=zh_cn&edition=full","pubTime":"2025-05-15 15:34","pubTimestamp":1747294495,"startTime":"0","endTime":"0","summary":"汇宇制药公告，公司董事会秘书张春平先生已取得上海证券交易所科创板董事会秘书任职培训证明，自2025年5月16日起正式履职。此前因未取得相关证明，其职责暂由财务总监高岚先生代行。张春平先生的任职资格已完成备案，联系方式已披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515155650a6e00c32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515155650a6e00c32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688553","BK0239"],"gpt_icon":0},{"id":"2535818729","title":"汇宇制药-W05月15日遭主力抛售257.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535818729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535818729?lang=zh_cn&edition=full","pubTime":"2025-05-15 15:20","pubTimestamp":1747293649,"startTime":"0","endTime":"0","summary":"05月15日, 汇宇制药-W股价跌0.88%，报收13.59元，成交金额2388.7万元，换手率0.51%，振幅1.46%，量比0.48。汇宇制药-W今日主力资金净流出257.8万元，连续4日净流出，上一交易日主力净流出9.8万元。该股近5个交易日下跌5.95%，主力资金累计净流出726.0万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2101.2万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515170404a47f5785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515170404a47f5785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2535725968","title":"汇宇制药-W05月13日遭主力抛售686.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535725968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535725968?lang=zh_cn&edition=full","pubTime":"2025-05-13 15:21","pubTimestamp":1747120904,"startTime":"0","endTime":"0","summary":"05月13日, 汇宇制药-W股价跌0.66%，报收13.64元，成交金额4591.1万元，换手率0.97%，振幅2.69%，量比0.75。汇宇制药-W今日主力资金净流出686.0万元，上一交易日主力净流出132.1万元。|05月13日主力加仓幅度排名||#|股票简称|主力净额占比|#|青岛金王|7.93%|#|长华化学|6.85%|#|酷特智能|6.02%|#|...|...|#3933|汇宇制药-W|-0.15%|汇宇制药-W所在的化学制药行业，今日主力净流出3.97亿元，行业排名29/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513173440a47c8127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250513173440a47c8127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2534021654","title":"破发股汇宇制药某股东拟清仓减持 上市即巅峰募24.7亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2534021654","media":"海峡网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534021654?lang=zh_cn&edition=full","pubTime":"2025-05-12 15:26","pubTimestamp":1747034760,"startTime":"0","endTime":"0","summary":"汇宇制药2024年年报显示，上海爽飒为公司第六大股东。上市当日，汇宇制药盘中最高报42.59元，创上市以来股价最高点，此后该股股价震荡走低。汇宇制药发行募集资金总额为24.72亿元，扣除发行费用后，募集资金净额为23.61亿元。汇宇制药发行费用合计1.11亿元，其中中信建投证券、国都证券获得承销费9887.48万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-05-12/doc-inewhxky8007790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2534024948","title":"汇宇制药-W05月12日主力净流出132.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2534024948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534024948?lang=zh_cn&edition=full","pubTime":"2025-05-12 15:21","pubTimestamp":1747034492,"startTime":"0","endTime":"0","summary":"05月12日, 汇宇制药-W股价跌2.49%，报收13.73元，成交金额8101.9万元，换手率1.72%，振幅4.40%，量比1.48。汇宇制药-W今日主力资金净流出132.1万元，上一交易日主力净流入359.8万元。该股近5个交易日下跌1.44%，主力资金累计净流出92.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流出1586.3万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512173311a6dc04e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512173311a6dc04e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2534022954","title":"【汇宇制药：上海爽飒拟减持公司不超2.997%股份】汇宇制药5月11日晚间公告，持股2.997%的公司股东上海爽飒企业管理咨询事务所拟减持公司股份不超过1269.56万股，即不超过公司总股本的2.997%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534022954","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534022954?lang=zh_cn&edition=full","pubTime":"2025-05-11 15:49","pubTimestamp":1746949758,"startTime":"0","endTime":"0","summary":"汇宇制药5月11日晚间公告，持股2.997%的公司股东上海爽飒企业管理咨询事务所拟减持公司股份不超过1269.56万股，即不超过公司总股本的2.997%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/11154950293456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688553","BK0239"],"gpt_icon":0},{"id":"2534402398","title":"汇宇制药(688553.SH)股东上海爽飒拟减持不超2.997%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2534402398","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534402398?lang=zh_cn&edition=full","pubTime":"2025-05-11 15:39","pubTimestamp":1746949184,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 汇宇制药(688553.SH)发布公告，因自身资金需求，股东上海爽飒拟通过集中竞价或大宗交易的方式减持公司股份不超过1269.56万股，合计减持股份比例不超过公司股份总数的2.997%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291709.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688553","BK0239"],"gpt_icon":0},{"id":"2534402307","title":"汇宇制药：股东上海爽飒拟减持不超过2.997%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2534402307","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534402307?lang=zh_cn&edition=full","pubTime":"2025-05-11 15:39","pubTimestamp":1746949166,"startTime":"0","endTime":"0","summary":"汇宇制药(688553.SH)公告称，股东上海爽飒企业管理咨询事务所（有限合伙）因自身资金需求，计划通过集中竞价或大宗交易的方式减持公司股份不超过12,695,629股，合计减持股份比例不超过公司股份总数的2.997%。减持期间为自公告披露之日起15个交易日后的3个月内。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051100001240.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2534748653","title":"汇宇制药收盘下跌2.56%，滚动市盈率23.54倍，总市值59.64亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534748653","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534748653?lang=zh_cn&edition=full","pubTime":"2025-05-09 20:07","pubTimestamp":1746792441,"startTime":"0","endTime":"0","summary":"5月9日，汇宇制药今日收盘14.08元，下跌2.56%，滚动市盈率PE达到23.54倍，总市值59.64亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均45.98倍，行业中值27.00倍，汇宇制药排名第76位。截至2025年一季报，共有6家机构持仓汇宇制药，其中其他3家、基金3家，合计持股数3384.68万股，持股市值5.43亿元。最新一期业绩显示，2025年一季报，公司实现营业收入2.39亿元，同比-1.46%；净利润-25626485.3元，同比-155.19%，销售毛利率83.62%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/09200750275912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688553","BK0239"],"gpt_icon":0},{"id":"2534486233","title":"汇宇制药产品获得境外上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2534486233","media":"港美通","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534486233?lang=zh_cn&edition=full","pubTime":"2025-05-09 20:01","pubTimestamp":1746792096,"startTime":"0","endTime":"0","summary":"四川汇宇制药股份有限公司5月9日收盘后发布公告称，子公司Seacross Pharma  Ltd.近期收到法国和西班牙药品监管机构核准签发的上市许可。该产品已在中国、英国、德国、荷兰、葡萄牙、爱尔兰、西班牙、意大利、法国获得上市许可，并已在沙特阿拉伯提交注册申请。汇宇制药表示，此次产品获得法国和西班牙的上市许可，有利于公司在国际市场的产品管线丰富，提升市场品牌形象，进一步拓展国际业务。公司已开展产品上市销售的前期准备工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050920182097547c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050920182097547c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2534178032","title":"汇宇制药(688553.SH)子公司两款产品分别获得法国、西班牙上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2534178032","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534178032?lang=zh_cn&edition=full","pubTime":"2025-05-09 16:39","pubTimestamp":1746779991,"startTime":"0","endTime":"0","summary":"智通财经APP讯，汇宇制药 发布公告，公司子公司Seacross PharmaLtd.近期收到法国国家药品和保健品安全局、西班牙国家药品和健康产品管理局分别核准签发的公司产品丙戊酸钠注射用浓溶液、注射用环磷酰胺的上市许可。据悉，丙戊酸钠注射用浓溶液是一种抗癫痫药，在成人和儿童中，当暂时不能服用口服剂型时，用于替代口服剂型，主要用于治疗全身性发作，表现为失神性发作、肌肉抽搐性发作、强直-阵挛性发作，以及局灶性和继发性全身性发作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1291338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"汇宇制药(688553.SH)子公司两款产品分别获得法国、西班牙上市许可","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688553","BK0239"],"gpt_icon":0},{"id":"2533797214","title":"汇宇制药-W05月08日主力净流入74.9万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533797214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533797214?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:21","pubTimestamp":1746688863,"startTime":"0","endTime":"0","summary":"05月08日, 汇宇制药-W股价涨1.62%，报收14.45元，成交金额4586.6万元，换手率0.93%，振幅2.81%，量比0.56。汇宇制药-W今日主力资金净流入74.9万元，上一交易日主力净流出105.6万元。该股近5个交易日上涨2.48%，主力资金累计净流出365.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1201.0万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508171942a4767676&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508171942a4767676&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2532873196","title":"汇宇制药获得发明专利授权：“高效液相色谱法检测甲氨蝶呤中间体及其对映异构体的方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2532873196","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532873196?lang=zh_cn&edition=full","pubTime":"2025-05-03 02:25","pubTimestamp":1746210357,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示汇宇制药新获得一项发明专利授权，专利名为“高效液相色谱法检测甲氨蝶呤中间体及其对映异构体的方法”，专利申请号为CN202310413973.7，授权日为2025年5月2日。今年以来汇宇制药新获得专利授权8个，较去年同期增加了100%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050300000896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2531083336","title":"汇宇制药-W04月30日主力净流出404.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2531083336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531083336?lang=zh_cn&edition=full","pubTime":"2025-04-30 15:21","pubTimestamp":1745997664,"startTime":"0","endTime":"0","summary":"04月30日, 汇宇制药-W股价跌1.07%，报收13.93元，成交金额5069.3万元，换手率1.06%，振幅1.99%，量比0.66。汇宇制药-W今日主力资金净流出404.0万元，上一交易日主力净流入358.3万元。该股近5个交易日下跌12.39%，主力资金累计净流出313.5万元；近20日主力资金累计净流出3103.2万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430164018a6ce8f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430164018a6ce8f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2531200351","title":"汇宇制药：首次公开发行股票并在科创板上市之保荐总结报告书","url":"https://stock-news.laohu8.com/highlight/detail?id=2531200351","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531200351?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:27","pubTimestamp":1745918849,"startTime":"0","endTime":"0","summary":"汇宇制药公告， 中信建投 证券作为其科创板IPO的保荐机构，完成了自2021年10月上市至2024年12月31日的持续督导工作。期间，保荐机构对公司的规范运作、信息披露、募集资金管理等进行了全面督导，并确认公司符合相关法规要求。截至2024年12月31日，公司首次公开发行股票募集资金尚未使用完毕，保荐机构将继续履行督导职责。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181315a46bec09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429181315a46bec09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159982","688553","BK0239"],"gpt_icon":0},{"id":"2531220519","title":"开源证券：给予汇宇制药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531220519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531220519?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:06","pubTimestamp":1745910389,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,刘艺近期对汇宇制药进行研究并发布了研究报告《公司信息更新报告：业绩表现亮眼，创新+出海持续推进》，给予汇宇制药买入评级。汇宇制药业绩表现亮眼，创新+出海持续推进，维持“买入”评级2024年公司收入10.94亿元；归母净利润3.25亿元；扣非归母净利润0.92亿元。公司高端仿制药扬帆出海，境外市场加速扩张。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291511209749b66a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504291511209749b66a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688553","161027"],"gpt_icon":0},{"id":"2530148515","title":"汇宇制药一季度亏损2563万元，营业收入2.39亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530148515","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530148515?lang=zh_cn&edition=full","pubTime":"2025-04-27 13:13","pubTimestamp":1745730780,"startTime":"0","endTime":"0","summary":"4月25日，汇宇制药公布2025年一季报，公司营业收入为2.39亿元，同比下降1.5%；归母净利润亏损2563万元，同比下降155.2%；扣非归母净利润为3441万元，同比下降8.3%；经营现金流净额为256万元，同比下降80.9%；EPS为-0.0605元。截至一季度末，公司总资产49.49亿元，较上年度末下降4.2%；归母净资产为39.53亿元，较上年度末下降0.7%。2025年第一季度的报告中，详细介绍了其业务情况及财务数据。报告显示，研发投入占营业收入的比例为28.06%，体现了对创新和产品开发的重视。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504271322469747039a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504271322469747039a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688553"],"gpt_icon":0},{"id":"2530002141","title":"汇宇制药一季度净利亏损2562.65万元，同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2530002141","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530002141?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:58","pubTimestamp":1745726280,"startTime":"0","endTime":"0","summary":"北京商报讯（记者丁宁）4月26日，汇宇制药（688553）发布2025年第一季度报告显示，一季度公司实现营业收入2.39亿元，同比下滑1.46%；归属净利润-2562.65万元，同比由盈转亏。针对业绩变动的原因，汇宇制药表示，系报告期持有同源康股价变动所致。（文章来源：北京商报）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504271215089746f7f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504271215089746f7f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688553","BK0239"],"gpt_icon":0},{"id":"2530217100","title":"汇宇制药拟每10股派发现金红利4.632元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530217100","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530217100?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:43","pubTimestamp":1745725408,"startTime":"0","endTime":"0","summary":"4月25日，汇宇制药（688553）发布公告，公司拟向全体股东每10股派发现金红利4.632元（含税），预计总派发金额为1.95亿元，占归母净利润的60.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042711442194e45a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042711442194e45a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688553"],"gpt_icon":0},{"id":"2530170829","title":"汇宇制药2025年一季报简析：净利润减155.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530170829","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530170829?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:24","pubTimestamp":1745706285,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期汇宇制药发布2025年一季报。根据财报显示，汇宇制药净利润减155.19%。截至本报告期末，公司营业总收入2.39亿元，同比下降1.46%，归母净利润-2562.65万元，同比下降155.19%。去年的净利率为28.87%，算上全部成本后，公司产品或服务的附加值高。持有汇宇制药最多的基金为信澳健康中国混合A，目前规模为5.32亿元，最新净值1.912，较上一交易日下跌1.49%，近一年下跌6.87%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063617a6c9b809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427063617a6c9b809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688553"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747347305089,"stockEarnings":[{"period":"1week","weight":-0.0595},{"period":"1month","weight":-0.148},{"period":"3month","weight":-0.1118},{"period":"6month","weight":-0.1798},{"period":"1year","weight":-0.017},{"period":"ytd","weight":-0.1059}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0102},{"period":"6month","weight":0.015},{"period":"1year","weight":0.0836},{"period":"ytd","weight":0.0087}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川汇宇制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"18434人(较上一季度增加4.80%)","perCapita":"18636股","listingDate":"2021-10-26","address":"四川省内江市市中区汉阳路333号3幢","registeredCapital":"42360万元","survey":"　　四川汇宇制药股份有限公司主营业务为肿瘤治疗领域药物和复杂注射剂药物的研发、生产和国内外销售。主要产品有原料药、抗肿瘤注射剂、肿瘤辅助用药、造影剂等。公司荣登“2022年四川省新经济100强企业榜单”；荣获“四川省2022年度科技创新引才引智先进基地”；荣获“2023年中国医药新锐创新力量”；荣获“四川企业技术创新发展能力100强”且名次跃升至第6位；再次斩获“四川企业技术创新发展最具潜力20强企业”；荣获“2023年度科技人才工作先进单位”表彰授牌。","listedPrice":38.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汇宇制药(688553)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汇宇制药(688553)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汇宇制药,688553,汇宇制药股票,汇宇制药股票老虎,汇宇制药股票老虎国际,汇宇制药行情,汇宇制药股票行情,汇宇制药股价,汇宇制药股市,汇宇制药股票价格,汇宇制药股票交易,汇宇制药股票购买,汇宇制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汇宇制药(688553)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汇宇制药(688553)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}